RxDoctor Payments Data

Enkhtsetseg Purev

Hematology & Oncology · Aurora, CONPI 1952662249

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,930 of the $5,385 with a category attached, or 73.0%. Novartis accounts for 73.0% of it on its own, with 2 other manufacturers making up the rest.

$5,385in general payments, 2019–2025

Across 8 payments — averaging $673.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$4K
  • Seagen Inc.$1K
  • Genentech, Inc.$322
$1,293,715in research payments, 2019–2025

Across 7 payments — averaging $184,816 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$1.3M

What the payments were for

  • Consulting fees$3,93073%
  • Travel & lodging$1,41726%
  • Food & beverage$381%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis1$3,930
Seagen Inc.5$1,132
Genentech, Inc.2$322

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,385 in reported general payments places this provider in the 60th percentile of 169 hematology & oncology providers in Colorado.

See all hematology & oncology providers in Colorado

Other hematology & oncology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →